• 1
    Guerin PJ, Olliaro P, Sundar S et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect. Dis. 2002; 2: 494501.
  • 2
    Low GC, Cooke WE. A congenial infection of kala azar. Lancet 1926; ii: 120911.
  • 3
    Banerji D. Possible congenial infection of kala-azar. J. Indian Med. Assoc. 1955; 24: 4335.
  • 4
    Blanc C, Robert A. Cinquie'me observation de kala-azar conge'nital. [Fifth observation of congenital Kala Azar]. Presse Med. 1984; 13: 1751.
  • 5
    Mishra J, Saxena A, Singh S. Chemotherapy of leishmaniasis: past, present and future. Curr. Med. Chem. 2007; 14: 115369.
  • 6
    Thakur CP, Singh SM, Hassan RK et al. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Trans. R. Soc. Trop. Med. Hyg. 1999; 93: 31928.